Recombinant Human Bone Morphogenetic Protein-2 in Posterolateral Spinal Fusion: What's the Right Dose?
Study DesignSingle center retrospective cohort analysis.PurposeThe goal was to evaluate the influence of varying amount of recombinant human bone morphogenetic protein 2 (rhBMP-2) per level on fusion rates and complications in posterolateral spinal fusions.Overview of LiteraturerhBMP-2 has been util...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Spine Society
2016-06-01
|
Series: | Asian Spine Journal |
Subjects: | |
Online Access: | http://www.asianspinejournal.org/upload/pdf/asj-10-457.pdf |